Home
Scholarly Works
20 Evaluating intermediate endpoints for overall...
Journal article

20 Evaluating intermediate endpoints for overall survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors: an IMDC study

Journal

The oncologist, Vol. 29, No. Suppl 1, pp. S8–S9

Publication Date

August 1, 2024

ISSN

1083-7159

Labels

Fields of Research (FoR)

Contact the Experts team